Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic l-amino acid transporter-related diseases
US11573240B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 18, 2016 |
| Grant date | Feb 7, 2023 |
| Priority date | — |
| Expiry date | Nov 18, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for diagnosing CAT1-related diseases, wherein the methods include detecting CAT1 in a cell by a BLV.RBD ligand, or a variant or a fragment thereof. Also disclosed is a BLV.RBD ligand, or a variant or a fragment thereof for use in the treatment of CAT1-related diseases and/or BLV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.